Simphotek

Simphotek is a private New Jersey-based health technology and photonics company developing software-enabled medical devices for photodynamic therapy (PDT). Its core healthcare offering is Dosie, a treatment-planning and dosimetry platform designed to model light distribution, photosensitizer activity, and tissue response so clinicians can personalize PDT for cancer patients. The company also developed SimphoSOFT, a broader photonics simulation environment that supports modeling of light-matter interactions and photoactive materials. Simphotek appears to operate at the intersection of oncology, biophotonics, and medical-device software, with a particular focus on improving repeatability and predictability of interstitial and intracavitary PDT. The company has received non-dilutive support including NIH funding and collaborates with academic and clinical partners on translational PDT applications.